| 头孢他啶、哌拉西林/他唑巴坦治疗血液病合并感染的疗效比较 |
| |
| 引用本文： | 彭捷,赵谢兰,陈方平. 头孢他啶、哌拉西林/他唑巴坦治疗血液病合并感染的疗效比较[J]. 中国药业, 2005, 14(2): 66-67 |
| |
| 作者姓名： | 彭捷 赵谢兰 陈方平 |
| |
| 作者单位： | 中南大学湘雅医院,湖南,长沙,410008 |
| |
| 摘 要： | 目的:比较头孢他啶与哌拉西林/他唑巴坦在治疗血液病合并感染中的疗效和安全性.方法:52例患者采用哌拉西林/他唑巴坦治疗,47例患者采用头孢他啶治疗.结果:两组总有效率和不良反应的差异均无统计学意义(P＞0.05).结论:两药均可作为免疫力低下患者合并感染的经验性治疗.
|
| 关 键 词： | 血液病 感染 头孢他啶 哌拉西林/他唑巴坦 疗效 |
| 文章编号： | 1006-4931(2005)02-0066-01 |
| 修稿时间： | 2004-04-23 |
The Comparison of the Efficacy of Ceftazidime and Piperacillin/Tazobactam in the Treatment of Hemopathy with Infections |
| |
| Peng Jie,Zhao Xielan,Chen Fangping. The Comparison of the Efficacy of Ceftazidime and Piperacillin/Tazobactam in the Treatment of Hemopathy with Infections[J]. China Pharmaceuticals, 2005, 14(2): 66-67 |
| |
| Authors: | Peng Jie Zhao Xielan Chen Fangping |
| |
| Abstract: | Objective:To compare the efficacy and safety of ceftazidime and piperacillin/tazobactam in the treatment of hemopathy with infections.Methods:Fifty two patients with hemopathy associated with infections were treated by piperacillin/tazobactam and forty seven patients were treated by ceftazidime.Results:There was no statistical significance of difference in the total efficiency and the rate of adverse reactions between the two groups(P > 0.05).Conclusion:The two kinds of medicine can be used empirically in the treatment of hemopathy with infections in patients with low immunity. |
| |
| Keywords: | hemopathy infection ceftazidime piperacillin/tazobactam efficacy |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
